Vancomycin continuous infusion in neonates: Dosing optimisation and therapeutic drug monitoring

Archives of Disease in Childhood

Volumn 98, Issue 6, 2013, Pages 449-453

  Zhao, Wei ^a,b   Lopez, Emmanuel ^c   Biran, Valérie ^a   Durrmeyer, Xavier ^d   Fakhoury, May ^a   Jacqz Aigrain, Evelyne ^a,b  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b INSERM   (France)

^c Institut Cochin   (France)

^d CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; CREATININE; IBUPROFEN; INOTROPIC AGENT; VANCOMYCIN;

ARTICLE; BIRTH WEIGHT; BODY WEIGHT; CONTINUOUS INFUSION; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG MONITORING; FEMALE; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL;

INFECTIOUS DISEASES; MONITORING; PHARMACOKINETICS; PHARMACOLOGY;

ANTI-BACTERIAL AGENTS; BIRTH WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; FEMALE; HUMANS; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; MALE; MODELS, THEORETICAL; VANCOMYCIN;

EID: 84877631293     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/archdischild-2012-302765     Document Type: Article

References (17)

1. de Hoog M, Mouton JW, van den Anker JN. Vancomycin: pharmacokinetics and administration regimens in neonates. Clin Pharmacokinet 2004;43:417-40. (Pubitemid 38716502)
2. Marsot A, Boulamery A, Bruguerolle B, et al. Vancomycin: a review of population pharmacokinetic analyses. Clin Pharmacokinet 2012;51:1-13.
3. Wysocki M, Delatour F, Faurisson F, et al. Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections:prospective multicenter randomized study. Antimicrob Agents Chemother 2009;53:1863-7.
4. Pea F, Furlanut M, Negri C, et al. Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients. Antimicrob Agents Chemother 2001;45:2460-7.
5. Plan O, Cambonie G, Barbotte E, et al. Continuous-infusion vancomycin therapy for preterm neonates with suspected or documented Gram-positive infections: a new dosage schedule. Arch Dis Child Fetal Neonatal Ed 2008;93:418-21.
6. Pawlotsky F, Thomas A, Kergueris MF, et al . Constant rate infusion of vancomycin in premature neonates: a new dosage schedule. Br J Clin Pharmacol 1998;46:163-7. (Pubitemid 28342788)
7. Oudin C, Vialet R, Boulamery A, et al. Vancomycin prescription in neonates and young infants: toward a simplifi ed dosage. Arch Dis Child Fetal Neonatal Ed 2011;96:365-70.
8. Wysocki M, Delatour F, Faurisson F, et al. Continuous versus intermittent infusion of vancomycin in severe staphylococcal infections: prospective multicenter randomized study. Antimicrob Agents Chemother 2001;45:2460-7. (Pubitemid 32801896)
9. Cataldo MA, Tacconelli E, Grilli E, et al. Continuous versus intermittent infusion of vancomycin for the treatment of gram-positive infections: systematic review and meta-analysis. J Antimicrob Chemother 2012;67:17-24.
10. Moise-Broder PA, Forrest A, Birmingham MC, et al. Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections. Clin Pharmacokinet 2004;43:925-42. (Pubitemid 39447034)
11. Anderson BJ, Allegaert K, Van den Anker JN, et al. Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance. Br J Clin Pharmacol 2007;63:75-84. (Pubitemid 44902880)
12. Zoetis T, Hurtt ME. Species comparison of anatomical and functional renal development. Birth Defects Res B Dev Reprod Toxicol 2003;68:111-20. (Pubitemid 38222008)
13. Rhodin MM, Anderson BJ, Peters AM, et al. Human renal function maturation: a quantitative description using weight and postmenstrual age. Pediatr Nephrol 2009;24:67-76.
14. De Cock RF, Allegaert K, Schreuder MF, et al. Maturation of the glomerular filtration rate in neonates, as reflected by amikacin clearance. Clin Pharmacokinet 2012;51:105-17.
15. Allegaert K, Anderson BJ, van den Anker JN, et al. Renal drug clearance in preterm neonates: relation to prenatal growth. Ther Drug Monit 2007;29:284-91. (Pubitemid 47262257)
16. Seay RE, Brundage RC, Jensen PD, et al. Population pharmacokinetics of vancomycin in neonates. Clin Pharmacol Ther 1994;56:169-75. (Pubitemid 24274183)
17. Jacqz-Aigrain E, Zhao W, Sharland M, et al. Use of antibacterial agents in the neonate: 50 years of experience with vancomycin administration. Semin Fetal Neonatal Med (Epub) (doi:pii: S1744-165X(12)00110-2. 10.1016/j.siny.2012. 10.003).